Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis.
The antibacterial susceptibility of Chlamydia trachomatis in 138 patients with chronic prostatitis (CP) and clinical failures after antibacterial treatment with azithromycin (AZI) were investigated. Azithromycin was not found to be top-of-the-line drug in the follow-up treatment, showing only average results in vitro. The investigation of the susceptibility of chlamydia to antibiotics in causes of chronic prostatitis is highly recommended.
Smelov
V
V
Department of Microbiology, St Petersburg State Medical University, St Petersburg, Russia. vsmelov@hotmail.com
Krylova
T
T
Smelova
N
N
Norman
L
L
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D011472:Prostatitis / Q000150:complications*
D000900:Anti-Bacterial Agents; D017963:Azithromycin